Literature DB >> 26828135

Global trends in incidence and mortality of nasopharyngeal carcinoma.

Ling-Ling Tang1, Wan-Qing Chen2, Wen-Qiong Xue1, Yong-Qiao He1, Rong-Shou Zheng2, Yi-Xin Zeng1, Wei-Hua Jia3.   

Abstract

Nasopharyngeal carcinoma (NPC) is a rare malignancy with an extraordinarily skewed geographic distribution worldwide. Although decreasing trends in incidence and mortality of NPC have been sporadically reported in some high-risk areas, no comprehensive description of the global trends has ever been made. We accessed incidence (1970-2007) and mortality (1970-2013) data from multiple sources, with the main ones being the Cancer Incidence in Five Continents (CI5) series and the World Health Organization (WHO) cancer mortality database. During the entire period studied, age-standardized incidence rates (ASIRs) of NPC decreased significantly in southern and eastern Asia, north America and Nordic countries with average annual percent changes (AAPCs) of -0.9% to -5.4% in males and -1.1% to -4.1% in females. Declines in age-standardized mortality rates (ASMRs) are even more remarkable and extensive, with AAPCs varying from -0.9% and -0.8% to -3.7% and -6.5% in males and females, respectively. Decreasing trends in NPC incidence are probably due to tobacco control, changes in diets and economic development. Declines in mortality rates are the results of advancements in diagnostic and radiotherapy techniques, as well as decreased incidence rates.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Incidence; Joinpoint analysis; Mortality; Nasopharyngeal carcinoma; Trends

Mesh:

Year:  2016        PMID: 26828135     DOI: 10.1016/j.canlet.2016.01.040

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  119 in total

1.  Predictive Value of [18F]ML-10 PET/CT in Early Response Evaluation of Combination Radiotherapy with Cetuximab on Nasopharyngeal Carcinoma.

Authors:  Bingxin Gu; Shuai Liu; Yuyun Sun; Jianping Zhang; Yongping Zhang; Xiaoping Xu; Huiyu Yuan; Mingwei Wang; Yingjian Zhang; Zhongyi Yang
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 2.  Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.

Authors:  Elaine Johanna Limkin; Pierre Blanchard
Journal:  Br J Radiol       Date:  2019-05-31       Impact factor: 3.039

3.  Occupational risk factors for nasopharyngeal carcinoma in Hong Kong Chinese: a case-referent study.

Authors:  Shao-Hua Xie; Ignatius Tak-Sun Yu; Lap Ah Tse; Joseph Siu Kie Au; June Sze Man Lau
Journal:  Int Arch Occup Environ Health       Date:  2017-03-02       Impact factor: 3.015

4.  Automatic Nasopharyngeal Carcinoma Segmentation Using Fully Convolutional Networks with Auxiliary Paths on Dual-Modality PET-CT Images.

Authors:  Lijun Zhao; Zixiao Lu; Jun Jiang; Yujia Zhou; Yi Wu; Qianjin Feng
Journal:  J Digit Imaging       Date:  2019-06       Impact factor: 4.056

5.  Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.

Authors:  Songbin Guo; Jinling Zhang; Cairong Wei; Zhiyong Lu; Rulong Cai; Danqi Pan; Hanbin Zhang; Baoxia Liang; Zhenfeng Zhang
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-24       Impact factor: 3.333

6.  [Down-regulation of miR-205-5p enhances pro-apoptotic effect of 3-bromopyruvate on human nasopharyngeal carcinoma CNE2Z cells].

Authors:  Zongfen Shi; Pei Zhang; Xingyue Lu; Chenlu Zhu; Changjiang Chen; Surong Zhao; Hao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

7.  A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.

Authors:  Yen-Bin Hsu; Ming-Chin Lan; Yu-Lun Kuo; Chi-Ying F Huang; Ming-Ying Lan
Journal:  Invest New Drugs       Date:  2019-04-16       Impact factor: 3.850

8.  [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells in vitro].

Authors:  Hao Wang; Wei Li; Guolin Tan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

9.  Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter Study.

Authors:  Richard Du; Victor H Lee; Hui Yuan; Ka-On Lam; Herbert H Pang; Yu Chen; Edmund Y Lam; Pek-Lan Khong; Anne W Lee; Dora L Kwong; Varut Vardhanabhuti
Journal:  Radiol Artif Intell       Date:  2019-07-10

10.  Depletion of MLKL inhibits invasion of radioresistant nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition.

Authors:  Yuanli Dong; Yun Sun; Yangle Huang; Xumeng Fang; Pian Sun; Bilikere Dwarakanath; Lin Kong; Jiade Jay Lu
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.